Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Naproxen 25 mg/mL oral suspension |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely tramadol hydrochloride 50 milligram/1 sachet effervescent powder for conventional release oral solution (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely tramadol hydrochloride 50 milligram/1 sachet effervescent powder for conventional release oral solution (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely micafungin (as micafungin sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Isoniazid 10 mg/mL oral solution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely nitrazepam 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Porfimer sodium 15 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Porfimer sodium 15 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Paclitaxel 100 mg powder for suspension for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Paclitaxel 100 mg powder for suspension for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
somatropin (rbe) 16 IE (5,33 mg), pulver til injektionsvæske, opløsning, cylinderampul |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
somatropin (rbe) 16 IE (5,33 mg), pulver til injektionsvæske, opløsning, cylinderampul |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Treosulfan 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Treosulfan 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Treosulfan 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely reteplase 10 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hemin 313 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Imiglucerase 400 unit powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Imiglucerase 400 unit powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Rifampicin 600 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Rifampicin 600 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely diazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
2 |
Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Remifentanil (as remifentanil hydrochloride) 1 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Diazepam 2 mg/mL oral suspension |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely methadone hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 200 microgram/1 syringe powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 200 microgram/1 syringe powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Raltitrexed 2 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Raltitrexed 2 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rbe) 12 milligram/1 cartridge powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 12 milligram/1 cartridge powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rbe) 600 microgram/1 syringe powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 600 microgram/1 syringe powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely clonazepam 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Verteporfin 15 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Verteporfin 15 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Paracetamol 100 mg/mL oral suspension |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
imipenem 500 mg + cilastatin 500 mg pulver til injektionsvæske, suspension, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
imipenem 500 mg + cilastatin 500 mg pulver til injektionsvæske, suspension, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rbe) 800 microgram/1 syringe powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Sulpiride 40 mg/mL oral solution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Phenytoin 18 mg/mL oral suspension |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rbe) 1.2 milligram/1 syringe powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rbe) 1.2 milligram/1 syringe powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Oxybutynin hydrochloride 1 mg/mL oral solution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|